US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Claritev Corporation

38.13

-5.1300-11.86%

Post-market: 38.130.00000.00%16:10 EST

Volume:500.48K

Turnover:19.34M

Market Cap:630.12M

PE:-1.82

High:43.85

Open:42.37

Low:37.95

Close:43.26

52wk High:74.07

52wk Low:4.80

Shares:16.53M

Float Shares:5.58M

Volume Ratio:1.25

T/O Rate:8.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.9031

EPS(LYR):-101.9248

ROE:-646.34%

ROA:0.96%

PB:-6.19

PE(LYR):-0.37

Loading ...

Overview Company News Filings

Claritev Corporation to Release Third Quarter 2025 Financial Results

BRIEF-Claritev And Io Health Forge Strategic Relationship

Claritev and iO Health partner to expand AI-driven management platform in MENA

Claritev and IO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the Mena Region

THOMSON REUTERS

Claritev Corp - Secures Exclusive Rights to Resell Optima AI in Mena

THOMSON REUTERS

Claritev Corporation Files Initial Beneficial Ownership Statement for SVP, Chief Accounting Officer Brock Albinson

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

Claritev Corporation Appoints Brock Albinson as Senior Vice President and Chief Accounting Officer

Claritev on Track for Longest Losing Streak Since January 2021 -- Data Talk

Claritev Currently Down Eight Consecutive Days, On Pace for Longest Losing Streak Since August 2023 -- Data Talk

Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)

Claritev Corporation Unveils Investor Presentation Highlighting Vision and Strategic Growth Initiatives

Claritev Corporation to Participate in Wells Fargo Healthcare Conference and Morgan Stanley Global Healthcare Conference

Claritev Is Maintained at Overweight by Piper Sandler

Dalton Travis, Pres. & CEO of Claritev Corporation, Reports Acquisition of Common Shares

Jerome Hogge, EVP and COO, Reports Acquisition of Common Shares in Claritev Corporation

Stock Track | Claritev Corporation Soars 5.95% Pre-Market on Strong Q2 Results and Improved Outlook

Claritev Corp reports results for the quarter ended June 30 - Earnings Summary

BRIEF-Claritev Reports Second Quarter 2025 Results

Claritev Q2 EPS $(3.81) Misses $(2.69) Estimate, Sales $241.57M Beat $231.04M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTEV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":38.13,"timestamp":1763413200000,"preClose":43.26,"halted":0,"volume":500480,"hourTrading":{"tag":"盘后","latestPrice":38.13,"preClose":38.13,"latestTime":"16:10 EST","volume":883,"amount":33668.05,"timestamp":1763413827570},"delay":0,"floatShares":5577143,"shares":16525644,"eps":-20.903133,"marketStatus":"Closed","change":-5.13,"latestTime":"11-17 16:00:00 EST","open":42.37,"high":43.85,"low":37.95,"amount":19335309.7472,"amplitude":0.136385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.903133,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1763456400000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":43.26,"postHourTrading":{"tag":"盘后","latestPrice":38.13,"preClose":38.13,"latestTime":"16:10 EST","volume":883,"amount":33668.05,"timestamp":1763413827570},"volumeRatio":1.247833,"impliedVol":1.0021,"impliedVolPercentile":0.4451},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5577143,"roa":"0.96%","roe":"-646.34%","lyrEps":-101.92478,"volumeRatio":1.247833,"shares":16525644,"dividePrice":0,"high":43.85,"amplitude":0.136385,"preClose":43.26,"low":37.95,"week52Low":4.8,"pbRate":"-6.19","psRate":"0.66","week52High":74.0699,"institutionHeld":0,"latestPrice":38.13,"eps":-20.903133,"divideRate":0,"volume":500480,"delay":0,"ttmEps":-20.903133,"open":42.37,"prevYearClose":14.78,"prevWeekClose":43.26,"prevMonthClose":65.1,"prevQuarterClose":53.08,"fiveDayClose":57.84,"twentyDayClose":58.52,"sixtyDayClose":72.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32},{"market":"US","date":"2025-05-08","symbol":"CTEV","fiscalQuarterEnding":"2025/03","expectedEps":-2.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-3.43},{"market":"US","date":"2025-02-25","symbol":"CTEV","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":-5.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1761195600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2025-11-14","current":-1.855224,"percent":0.022346,"low":-3.349365,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"high":-0.170756,"avg":-0.87383,"sd":0.664146,"marketCap":730433464},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464}],"updateTime":1763400576621},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575271053","title":"Claritev Corporation to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2575271053","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575271053?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:00","pubTimestamp":1760612446,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on October 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDLb0bZNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2574970460","title":"BRIEF-Claritev And Io Health Forge Strategic Relationship","url":"https://stock-news.laohu8.com/highlight/detail?id=2574970460","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574970460?lang=en_us&edition=fundamental","pubTime":"2025-10-09 05:10","pubTimestamp":1759957846,"startTime":"0","endTime":"0","summary":"BRIEF-Claritev And Io Health Forge Strategic RelationshipOct 8 (Reuters) - Claritev Corp CTEV.N:CLARITEV AND IO HEALTH FORGE STRATEGIC RELATIONSHIP TO BRING AI-POWERED REVENUE CYCLE MANAGEMENT OPTIMIZ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP26K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2574977482","title":"Claritev and iO Health partner to expand AI-driven management platform in MENA","url":"https://stock-news.laohu8.com/highlight/detail?id=2574977482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574977482?lang=en_us&edition=fundamental","pubTime":"2025-10-09 04:35","pubTimestamp":1759955715,"startTime":"0","endTime":"0","summary":"Claritev (CTEV) and iO Health-FZE, a provider of AI-driven healthcare technology, announced a strategic agreement aimed at delivering Optima AI acr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-and-io-health-partner-to-expand-ai-driven-management-platform-in-mena-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-and-io-health-partner-to-expand-ai-driven-management-platform-in-mena-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4543","BK4551","BK4585","BK4023","BK4588","BK4587","CTEV","BK4167","BK4528"],"gpt_icon":0},{"id":"2574977809","title":"Claritev and IO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the Mena Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2574977809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574977809?lang=en_us&edition=fundamental","pubTime":"2025-10-09 04:30","pubTimestamp":1759955449,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP26K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2574977802","title":"Claritev Corp - Secures Exclusive Rights to Resell Optima AI in Mena","url":"https://stock-news.laohu8.com/highlight/detail?id=2574977802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574977802?lang=en_us&edition=fundamental","pubTime":"2025-10-09 04:30","pubTimestamp":1759955449,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP26K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2572557510","title":"Claritev Corporation Files Initial Beneficial Ownership Statement for SVP, Chief Accounting Officer Brock Albinson","url":"https://stock-news.laohu8.com/highlight/detail?id=2572557510","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572557510?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:16","pubTimestamp":1759349806,"startTime":"0","endTime":"0","summary":"Claritev Corporation has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing lists Brock Albinson as the beneficial owner, serving as Senior Vice President and Chief Accounting Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL43hj1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2571170333","title":"Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus","url":"https://stock-news.laohu8.com/highlight/detail?id=2571170333","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571170333?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:00","pubTimestamp":1759147200,"startTime":"0","endTime":"0","summary":"– Patent covers esophagus produced using Humacyte’s proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus – – Patent provides coverage into 20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/29/3157670/0/en/Humacyte-Announces-Expansion-of-Intellectual-Property-for-Pipeline-Products-with-Granting-of-New-U-S-Patent-for-Bioengineered-Esophagus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2570832158","title":"Claritev Corporation Appoints Brock Albinson as Senior Vice President and Chief Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2570832158","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570832158?lang=en_us&edition=fundamental","pubTime":"2025-09-27 04:24","pubTimestamp":1758918270,"startTime":"0","endTime":"0","summary":"Claritev Corporation has announced the appointment of Brock Albinson as Senior Vice President and Chief Accounting Officer, effective September 29, 2025. Albinson will also serve as the company's principal accounting officer, succeeding Gerald Kozel. Prior to joining Claritev, Albinson held financial management roles at Automatic Data Processing, Inc., most recently serving as Corporate Controller and Principal Accounting Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 26, 2025, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL5knMt4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374615.EUR","ADP","LU2506952170.USD","LU0861579265.USD","LU2506951958.HKD","LU0545562505.USD","LU0345774631.USD","BK4130","BK4613","LU0823417737.USD","GB00B4LPDJ14.GBP","CTEV","LU1228905540.USD","LU1691799644.USD","LU2404859741.USD","LU1934455277.USD","LU2404859667.USD","LU0965508806.USD","LU0345774391.USD","BK4106","LU0965509010.AUD","BK4588","BK4585","LU0289941410.SGD","LU1037948897.HKD","LU2506951875.HKD","LU0823417653.USD","BK4528","LU0965509101.SGD","LU1236620834.HKD","IE00B5TLWC47.USD","LU1934455194.USD","LU1037948541.HKD","LU1934455863.HKD","IE00BYQQ9H92.USD","LU2506952097.USD","LU0965509283.SGD","IE00BFXG0V08.USD","LU1032955483.USD","LU1221951046.USD","LU1196500208.SGD","LU1221951129.SGD","GB00B4QBRK32.GBP","LU1236620750.USD","LU0690374961.EUR","LU1228905037.USD","BK4167","LU0950375773.USD"],"gpt_icon":0},{"id":"2569739173","title":"Claritev on Track for Longest Losing Streak Since January 2021 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2569739173","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569739173?lang=en_us&edition=fundamental","pubTime":"2025-09-23 00:36","pubTimestamp":1758558960,"startTime":"0","endTime":"0","summary":"Claritev Corporation Class A  is currently at $50.13, down $1.60 or 3.09%. --Would be lowest close since Aug. 5, 2025, when it closed at $39.52. --Currently down nine consecutive days; down 30.81% over this period. --Longest losing streak since Jan. 6, 2021, when it fell for nine straight trading days. --Worst nine-day stretch since the nine days ending March 7, 2025, when it fell 37.47%. --Down 89.53% from its all-time closing high of $478.80 on July 17, 2020. --Up 460.11% from 52 weeks ago , when it closed at $8.95. --Down 30.93% from its 52-week closing high of $72.58 on Aug. 26, 2025. --Traded as low as $48.85; lowest intraday level since Aug. 6, 2025, when it hit $38.84","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2568295685","title":"Claritev Currently Down Eight Consecutive Days, On Pace for Longest Losing Streak Since August 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568295685","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568295685?lang=en_us&edition=fundamental","pubTime":"2025-09-20 03:11","pubTimestamp":1758309060,"startTime":"0","endTime":"0","summary":"Claritev Corporation Class A  is currently at $52.50, down $2.90 or 5.23%. --Would be lowest close since Aug. 6, 2025, when it closed at $51.14. --On pace for largest percent decrease since Sept. 10, 2025, when it fell 12.77%. --Currently down eight consecutive days; down 27.54% over this period. --Longest losing streak since Aug. 18, 2023, when it fell for eight straight trading days. --Down 89.04% from its all-time closing high of $478.80 on July 17, 2020. --Up 597.7% from 52 weeks ago , when it closed at $7.52. --Down 27.67% from its 52-week closing high of $72.58 on Aug. 26, 2025. --Up 907.58% from its 52-week closing low of $5.21 on Nov. 19, 2024. --Traded as low as $52.49; lowest intraday level since Aug. 7, 2025, when it hit $49.99. --Down 5.24% at today's intraday low; largest intraday percent decrease since Sept. 10, 2025, when it fell as much as 13.5%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2568973479","title":"Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568973479","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568973479?lang=en_us&edition=fundamental","pubTime":"2025-09-18 19:00","pubTimestamp":1758193200,"startTime":"0","endTime":"0","summary":"- Results were published in JACC: Basic to Translational Science - - Publication evaluated coronary tissue engineered vessel (CTEV) as a conduit for CABG in a nonhuman primate model - - All implanted ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/18/3152275/0/en/Humacyte-Announces-Publication-of-Preclinical-Data-on-Use-of-the-CTEV-as-a-Coronary-Artery-Bypass-Graft-CABG.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167","RCA"],"gpt_icon":0},{"id":"2564398634","title":"Claritev Corporation Unveils Investor Presentation Highlighting Vision and Strategic Growth Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2564398634","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564398634?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:49","pubTimestamp":1756900140,"startTime":"0","endTime":"0","summary":"Claritev Corporation recently released an investor presentation outlining the company's strategic growth initiatives and business goals. The presentation highlights Claritev's focus on de-leveraging to enhance cash flow and flexibility, as well as diversifying their product offerings and capital structure. Additionally, the company aims to accelerate growth potential through new investments and acquisitions. Claritev emphasizes its experienced management team and the favorable regulatory environment as key drivers for future success. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on September","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDLVQvNy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2562727174","title":"Claritev Corporation to Participate in Wells Fargo Healthcare Conference and Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2562727174","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562727174?lang=en_us&edition=fundamental","pubTime":"2025-08-28 04:05","pubTimestamp":1756325127,"startTime":"0","endTime":"0","summary":"Claritev Corporation, a technology, data, and insights company focused on making healthcare more affordable and transparent, will participate in the 2025 Wells Fargo Healthcare Conference on September 3, 2025, at the Encore Boston Harbor, Boston, MA. The presentation is scheduled for approximately 8:45 am Eastern Time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on August 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDLWDx6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2559591163","title":"Claritev Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2559591163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559591163?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:10","pubTimestamp":1755259800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 15, 2025 08:10 ET (12:10 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV"],"gpt_icon":0},{"id":"2559167621","title":"Dalton Travis, Pres. & CEO of Claritev Corporation, Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559167621","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559167621?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:19","pubTimestamp":1755029994,"startTime":"0","endTime":"0","summary":"Dalton Travis, President, CEO & Executive Chair of Claritev Corporation, reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL5fJJhH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2558969819","title":"Jerome Hogge, EVP and COO, Reports Acquisition of Common Shares in Claritev Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2558969819","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558969819?lang=en_us&edition=fundamental","pubTime":"2025-08-12 04:21","pubTimestamp":1754943715,"startTime":"0","endTime":"0","summary":"Jerome Hogge, EVP and Chief Operating Officer of Claritev Corporation, reported an acquisition of common shares of Claritev Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250811:nNDLBRk7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"1183108451","title":"Stock Track | Claritev Corporation Soars 5.95% Pre-Market on Strong Q2 Results and Improved Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1183108451","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183108451?lang=en_us&edition=fundamental","pubTime":"2025-08-06 21:59","pubTimestamp":1754488796,"startTime":"0","endTime":"0","summary":"Claritev Corporation (CTEV) shares are soaring 5.95% in pre-market trading on Wednesday following the release of its second-quarter 2025 financial results. The technology, data, and insights company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CTEV"],"gpt_icon":0},{"id":"2557370237","title":"Claritev Corp reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557370237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557370237?lang=en_us&edition=fundamental","pubTime":"2025-08-06 21:32","pubTimestamp":1754487138,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended June 30 - Earnings SummaryClaritev Corp CTEV.N reported a quarterly adjusted loss of $3.81 per share for the quarter ended June 30, higher than the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nL8N3TY1RO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV"],"gpt_icon":0},{"id":"2557372183","title":"BRIEF-Claritev Reports Second Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557372183","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557372183?lang=en_us&edition=fundamental","pubTime":"2025-08-06 20:51","pubTimestamp":1754484669,"startTime":"0","endTime":"0","summary":"BRIEF-Claritev Reports Second Quarter 2025 ResultsAug 6 (Reuters) - Claritev Corp CTEV.N:CLARITEV CORPORATION REPORTS SECOND QUARTER 2025 RESULTSCLARITEV CORP - REPORTS Q2 2025 REVENUES OF $241.6 MILL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nTUA6MFFNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2557272003","title":"Claritev Q2 EPS $(3.81) Misses $(2.69) Estimate, Sales $241.57M Beat $231.04M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557272003","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557272003?lang=en_us&edition=fundamental","pubTime":"2025-08-06 18:01","pubTimestamp":1754474490,"startTime":"0","endTime":"0","summary":"Claritev Q2 EPS $(3.81) Misses $(2.69) Estimate, Sales $241.57M Beat $231.04M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46888245/claritev-q2-eps-3-81-misses-2-69-estimate-sales-241-57m-beat-231-04m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":80,"code":"91000000","status":"200"}]}}